Table 1.
Clinical characteristics and flow cytometry analysis in GT patients
| Patient (sex) | Bleeding severity | Bleeding time, min | CD41 anti-αllb, % | CD42a anti-GPMX, % | CD42b anti-GPIbα, % |
|---|---|---|---|---|---|
| TA (M)+ | severe | 33 | <1 | 99 | 105 |
| TG (M)+ | severe | >30 | <1 | 107 | 111 |
| TN (F)° | mild | 9 | 90 | 109 | 110 |
| TF (M)° | none | 6.5 | 78 | 94 | 93 |
| GE (F) | severe | 21 | <1 | 108 | 87 |
| CM (F)° | mild | 58 | 99 | 93 | |
| SB (F) | moderate | >15 | 23 | 120 | 125 |
| YF (M) | moderate | 3 | n.a. | 73 | |
| TE (M) | severe | <1 | 110 | 122 | |
| GI (F)° | mild | 97 | 102 | 103 | |
| TA (M)° | mild | 90 | 99 | 109 | |
| DZ (F) | 0 | 103 | 110 | ||
| LN (F) | <1 | 98 | 96 | ||
| LH (F)° | 67 | 130 | 129 | ||
| LB (M)° | 82 | 101 | 104 | ||
| HM (M) | moderate | 0 | normal | normal | |
| HS (F)° | n.a. | n.a. | n.a. | ||
| HA (M)° | n.a. | n.a. | n.a. | ||
| OK (F) | severe | >30 | 4 | 101 | 114 |
| MM (M) | severe | <1 | 98 | 97 | |
| MU (F)° | 82 | 94 | 86 | ||
| WC (M) | severe | 0 | 119 | 113 | |
| WV (F)° | 68 | 121 | 113 | ||
| WA (M)° | 78 | 101 | 84 | ||
| PJ (M) | severe | <1 | normal | normal |
F = Female; M = male; n.a. = not available
+
= siblings
°
= parents.